Latest Organ failure Stories
LAWRENCE, Mass., Feb. 14, 2013 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM) is reinforcing its efforts with patients, care partners and renal professionals to increase awareness about the benefits of home hemodialysis (HHD) and advocate for reimbursement policy changes with the Centers for Medicare and Medicaid Services (CMS) specifically as it relates to reimbursement for HHD training. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) Today, the Company...
SAN DIEGO, Feb. 11, 2013 /PRNewswire/ -- Leading critical care experts will discuss new techniques for assessing risk of acute kidney injury (AKI) at an educational symposium to be held at the Eighteenth International Conference on Continuous Renal Replacement Therapies (CRRT) in San Diego. The symposium, "New AKI Biomarkers: A Revolution in Risk Assessment," will be held on Thursday, February 14, 2013, from 12:40 p.m. to 2:00 p.m. local time. Interested participants can visit...
Dietary changes reduce metabolic acidosis and kidney injury in kidney disease patients Highlight: -Adding fruits and vegetables to the diet is an effective alternative to medication to reduce metabolic acidosis and kidney injury in late-stage chronic kidney disease. -Metabolic acidosis is a common complication of kidney disease. Adding fruits and vegetables to the diet may help protect the kidneys of patients with chronic kidney disease (CKD) with too much acid build-up, according...
WASHINGTON, Feb. 6, 2013 /PRNewswire-USNewswire/ -- Two biomarkers used in combination can improve risk assessment of acute kidney injury (AKI), according to new research from an international multi-center study. AKI strikes up to seven percent of hospitalized patients and is associated with significant morbidity and mortality. The results, published today in Critical Care, address one of the most costly and deadly conditions affecting critically ill hospitalized patients. The...
African Americans, individuals without private insurance less likely to receive a transplant before needing dialysis Highlights: African Americans and individuals without private health insurance are less likely to receive a kidney transplant before needing dialysis. Geographic region is not a major factor in determining whether a patient receives a kidney transplant before starting dialysis. Nearly 90,000 people in the U.S. are waiting for a kidney transplant, and many will die...
Despite a substantial increase in the number of people suffering the debilitating and often deadly effects of heart failure, treatments for the condition have not advanced significantly for at least 10 years. An analysis by researchers at the University of North Carolina School of Medicine shows new breakthroughs could be closer than we thought. The analysis points to striking similarities between heart cells in patients with heart failure and brain cells in patients with Alzheimer's...
Absolute risk still low, but doctors and patients should be vigilant Patients who take a triple combination of blood pressure drugs and common painkillers are at an increased risk of serious kidney problems, especially at the start of treatment, finds a study published on bmj.com today. Although the absolute risk for individuals is low, it is still something doctors and patients should be aware of, say the researchers. Acute kidney injury (also known as kidney failure) is a major...
ATLANTA, Jan. 9, 2013 /PRNewswire/ -- Jay S. Yadav, MD, CEO and founder of CardioMEMS, has been named a recipient of the Industry Growth Award, the highest honor bestowed each year by Georgia Bio for extraordinary contributions to the growth of Georgia's life sciences industry. Dr. Yadav was recognized for his success as an entrepreneur and leader of Georgia's bioscience community, as well as his leadership at CardioMEMS', pioneering work in developing and marketing wireless...
Acquisition Includes Replidea(TM) and Alpharen(TM), Both in Phase 3 Clinical Trials with Kidney Disease Patients MARKHAM, ON, Jan. 8, 2013 /PRNewswire/ - Cytochroma today announced that it has entered into a definitive agreement with OPKO Health, Inc. (NYSE:OPK) under which Cytochroma, a privately held pharmaceutical company with operations in Markham, ON and Bannockburn, IL, will be acquired by OPKO. Through this transaction, OPKO will acquire worldwide rights to Cytochroma's two...
NEW YORK, Jan. 7, 2013 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) today announced that its Japanese partner, Japan Tobacco Inc. (JT), has filed its New Drug Application (NDA) with the Japanese Ministry of Health, Labour and Welfare for marketing approval of ferric citrate in Japan for the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD). The NDA filing is supported by efficacy and safety data from several successfully completed Phase 3...
